Your session is about to expire
← Back to Search
Tonometry
TonoVera Tonometer for Glaucoma
N/A
Recruiting
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Upbaseline only
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing how accurate the Reichert's Tono-Vera tonometer is compared to other commonly used tonometers.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline only
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline only
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Intraocular Pressure
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: IOP MeasurementExperimental Treatment2 Interventions
These are the measurements of the intraocular pressure.
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
238 Previous Clinical Trials
48,502 Total Patients Enrolled
3 Trials studying Glaucoma
156 Patients Enrolled for Glaucoma
Reichert, Inc.Industry Sponsor
2 Previous Clinical Trials
97 Total Patients Enrolled
1 Trials studying Glaucoma
61 Patients Enrolled for Glaucoma
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are able to provide signed and dated informed consent formYou have a condition where the white part of your eye is abnormally thin.You cannot have an accurate eye pressure reading due to eye conditions like blepharospasm, nystagmus, or extensive corneal problems. Contact lens wearers who can't remove their lenses will also be excluded.
Research Study Groups:
This trial has the following groups:- Group 1: IOP Measurement
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are investigators presently looking for participants for this research?
"Yes, this study is still recruiting patients as of 8/29/2022, according to the latest information available on clinicaltrials.gov. The trial was first posted on 8/1/2022."
Answered by AI
Who else is applying?
What state do they live in?
Connecticut
What site did they apply to?
Ross Eye Institute
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger